AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
The Canadian drug discovery/development company Cardiome Pharma Corp has received notice from the Anglo-Swedish drug manufacturer AstraZeneca Plc that it does not intend to proceed with development of Cardiome's RSD1122 pre-clinical compound.
AstraZeneca plans to return all rights and data associated with the compound to Cardiome. The Canadian …